Viral Entry as the Primary Target for the Anti-HIV Activity of Chicoric Acid and Its Tetra-Acetyl Esters

Authors:

Abstract
The antiviral activity of l-chicoric acid against HIV-1 has been attributed previously to the inhibition of HIV-1 integration. This conclusion was based on the inhibition of integrase activity in enzymatic assays and the isolation of a resistant HIV strain with a mutation (G140S) in the integrase gene. Here we show that the primary antiviral target of l-CA and its analogs in cell culture is viral entry. l- and d-chicoric acid (l-CA and d-CA) and their respective tetra-acetyl esters inhibit the replication of HIV-1 (IIIBand NL4.3) and HIV-2 (ROD) in MT-4 cells at a 50% effective concentration (EC50) ranging from 1.7 to 70.6 μM. In a time-of-addition experiment, l-CA, d-CA,l-CATA, and d-CATA were found to interfere with an early event in the viral replication cycle. Moreover,l-CA, d-CA, and their analogs did not inhibit the replication of virus strains that were resistant toward polyanionic and polycationic compounds at subtoxic concentrations. Furthermore, HIV-1 strains resistant to l-CA and d-CA were selected in the presence of l-CA and d-CA, respectively. Mutations were found in the V2, V3, and V4 loop region of the envelope glycoprotein gp120 of the l-CA andd-CA-resistant NL4.3 strains that were not present in the wild-type NL4.3 strain. Recombination of the gp120 gene of the l-CA and d-CA resistant strain in a NL4.3 wild-type molecular clone fully rescued the phenotypic resistance toward l-CA and d-CA. No significant mutations were detected in the integrase gene of the drug-resistant virus strains. Although inhibition of HIV integrase activity byl-CA and its derivatives was confirmed in an oligonucleotide-driven assay, integrase carrying the G140S mutation was inhibited to the same extent as the wild-type integrase.

This publication has 39 references indexed in Scilit: